Frontiers in Endocrinology | Gut Endocrinology

Original Research

Accepted on 17 Aug 2026

Association Between the Triglyceride-Glucose Index and the Presence and Severity of Hemorrhoidal Disease: A Cross-Sectional Study Based on Retrospectively Collected Clinical Data

in Gut Endocrinology

Li Tingting
Li Jiang
Hanwen Yang
Jianan Li

Frontiers in Endocrinology

Review

Accepted on 14 Aug 2026

The Gut Microbiome–Cardiometabolic Axis: Insights into Obesity, Type 2 Diabetes, and Hypertension

in Gut Endocrinology

Jhommara Bautista
Ronald Hernández-León
Alexandra Valencia Valverde
Andrés López-Cortés

Frontiers in Endocrinology

514 views

Review

Accepted on 03 Aug 2026

The Gut Microbiome in Polycystic Ovary Syndrome: Mechanistic Pathways and Therapeutic Potential of Microbiota-Targeted Interventions

in Gut Endocrinology

Farah Elhennawy
Basmalah Naji
Alexandra E Butler

Frontiers in Endocrinology

214 views

Original Research

Published on 03 Aug 2026

Combining MRI dual-sequence radiomics and clinical parameters predicts post-hypertriglyceridemic acute pancreatitis diabetes mellitus

in Gut Endocrinology

Yanting Li
Xiyao Wan
Yuan Wang
Hangyu Li
Cui Tang
Wang Zeng
Xiaohua Huang

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1887050

449 views

Mini Review

Published on 31 Jul 2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

in Gut Endocrinology

Melissa A. Burmeister
Skyler A. Brown
Jakeem J. Greer
Tyler J. Hoggatt
Whitney T. Zumwalt

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1925534

622 views

Review

Published on 24 Jul 2026

Bile acid signaling: from dynamic pool composition to inter-organ communication

in Gut Endocrinology

Fuyu Yang
Ting Wei
Kai Liu
Huikuan Chu
Ling Yang

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1890710

971 views

Clinical Trial

Published on 15 Jul 2026

Acute TRPTI™ (oleoylethanolamide) supplementation enhances incretin hormone responses: a fixed-sequence crossover study

in Gut Endocrinology

David Briskey
Janice Pellow
Pavitra Viswanath
Amanda Rao

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1879799

1,072 views

Mini Review

Published on 08 Jul 2026

“Envbiotics” -- a novel framework for microbiota-targeted therapeutic strategies in type 2 diabetes mellitus

in Gut Endocrinology

Wenxiao Wang
Long Xu
Ping Leng
Man Jiang
Xiaomin Xing
Mingchen Cao
Fanbo Jing

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1878037

1,013 views

Review

Published on 26 Jun 2026

Microbiota-mediated mechanisms of natural products in atherosclerosis: focus on metabolic and inflammatory pathways

in Gut Endocrinology

Qi Shen
Ce Bian
Mengjun Zhou
Xingkun Shen
Xiaodong Jin
Bo Li

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1818349

1,287 views

Review

Published on 24 Jun 2026

Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut

in Gut Endocrinology

Aleksandra Kopacz
Zuzanna Tomaszewska
Aleksandra Piechota-Polanczyk

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1861565

1,485 views

Original Research

Published on 22 Jun 2026

Association of metabolic dysfunction-associated steatotic liver disease trajectories with incident liver cancer: a UK Biobank cohort study

in Gut Endocrinology

Ryuk Jun Kwon
Yohwan Lim

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1851106

1,237 views
1 citation

Review

Published on 18 Jun 2026

Chinese herbal formulas for Hashimoto’s thyroiditis based on the thyroid-gut axis: multitarget synergistic mechanisms and boundaries of evidence

in Gut Endocrinology

Yujia Wu
Hongquan Shen
Jie Wang
Wenjun Sha
Zhidan Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1840643

1,667 views

Original Research

Published on 15 Jun 2026

The clinical value of analyzing predictive models for gastric function and gastric organic lesions

in Gut Endocrinology

Youlin Song
Yi Hu
Kang Wang
Yanhua Zhu
Yang Wang
Tao Liu
Lihao Wu
Xingxiang He
Lei Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1852014

1,176 views

Correction

Published on 15 Jun 2026

Correction: Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation

in Gut Endocrinology

Yi Chen
Danru Jin
Xue Han
Xiaoting Liu
Yisi Liu
Li Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1899890

762 views

Review

Published on 04 Jun 2026

Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions

in Gut Endocrinology

Chuying Yu
Xintong Ye
Haoyu Zhao
Suting Qian
Feifei Xie
Qingsheng Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1837504

1,846 views

Systematic Review

Published on 03 Jun 2026

Changes in incretin hormone concentrations after pancreaticoduodenectomy: a systematic review and exploratory meta-analysis

in Gut Endocrinology

Oliwia Grząsiak-Kraj
Tomasz Kraj
Krzysztof Poznański
Aneta Szmiel
Janusz Strzelczyk

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1845925

1,458 views

Review

Published on 02 Jun 2026

Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation

in Gut Endocrinology

Yi Chen
Danru Jin
Xue Han
Xiaoting Liu
Yisi Liu
Li Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1856667

3,175 views
1 citation

Original Research

Published on 25 May 2026

Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling

in Gut Endocrinology

Carl I. W. Larson
Melania Aluia
Eric Schéle
Suzanne L. Dickson
Anna Casselbrant
Ville Wallenius

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1833946

1,304 views

Original Research

Published on 13 May 2026

Mapping the gut microbiota-diabetic peripheral neuropathy research landscape: a bibliometric analysis of emerging trends and translational frontiers

in Gut Endocrinology

Yuda Fei
Peng Mao
Bifa Fan

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1815280

1,889 views

Original Research

Published on 05 May 2026

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

in Gut Endocrinology

Zhang Lingyu
Feng Peng
Zhong Wanting
Jin Qianqian
Zijuan Zhang
Bo Bai
Guofang Xue
Christian Hölscher

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1825379

2,892 views

Editorial

Published on 05 May 2026

Editorial: Impact of dietary factors on human gut microbiota and gastrointestinal endocrinology

in Gut Endocrinology

Patrik Hansson
Mari C.W. Myhrstad
Lara Costantini

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1858858

1,109 views

Review

Published on 24 Apr 2026

Microgravity as a translational model for metabolic dysfunction: implications for obesity, insulin resistance, steatotic liver and pancreatic diseases

in Gut Endocrinology

Mathew Vadukoot Lazar
Arun C. S. Menon
Rajesh Gopalakrishna

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1820707

2,475 views

Review

Published on 16 Apr 2026

Faecal microbiota transplantation and glucolipid metabolic disorders: the interventional role of gut microbiota

in Gut Endocrinology

Jiali Wu
Yusheng Qiu
Jiaying Deng
Yangpeng Li
Biao Jia
Zheng Cao
Jiaqing Tao
Jiao Guo

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1806638

3,477 views

Review

Published on 16 Apr 2026

Current status of research on the risk factors and pathogenesis of metabolic dysfunction-associated steatotic liver disease

in Gut Endocrinology

Dan Chen
Lingling Yan
Tong Wu
Junpeng Zhao
Xuebing Xu
Weisong Xu
Hong Zhang
Mingbing Xiao

Frontiers in Endocrinology

doi 10.3389/fendo.2026.1819756

2,304 views
1 citation

240 articles

articles

Association Between the Triglyceride-Glucose Index and the Presence and Severity of Hemorrhoidal Disease: A Cross-Sectional Study Based on Retrospectively Collected Clinical Data

The Gut Microbiome–Cardiometabolic Axis: Insights into Obesity, Type 2 Diabetes, and Hypertension

The Gut Microbiome in Polycystic Ovary Syndrome: Mechanistic Pathways and Therapeutic Potential of Microbiota-Targeted Interventions

Combining MRI dual-sequence radiomics and clinical parameters predicts post-hypertriglyceridemic acute pancreatitis diabetes mellitus

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Bile acid signaling: from dynamic pool composition to inter-organ communication

Acute TRPTI™ (oleoylethanolamide) supplementation enhances incretin hormone responses: a fixed-sequence crossover study

“Envbiotics” -- a novel framework for microbiota-targeted therapeutic strategies in type 2 diabetes mellitus

Microbiota-mediated mechanisms of natural products in atherosclerosis: focus on metabolic and inflammatory pathways

Estrogen receptors and the NRF2 pathway: bridging hormonal regulation and stress response in the gut

Association of metabolic dysfunction-associated steatotic liver disease trajectories with incident liver cancer: a UK Biobank cohort study

Chinese herbal formulas for Hashimoto’s thyroiditis based on the thyroid-gut axis: multitarget synergistic mechanisms and boundaries of evidence

The clinical value of analyzing predictive models for gastric function and gastric organic lesions

Correction: Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation

Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions

Changes in incretin hormone concentrations after pancreaticoduodenectomy: a systematic review and exploratory meta-analysis

Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation

Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling

Mapping the gut microbiota-diabetic peripheral neuropathy research landscape: a bibliometric analysis of emerging trends and translational frontiers

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

Editorial: Impact of dietary factors on human gut microbiota and gastrointestinal endocrinology

Microgravity as a translational model for metabolic dysfunction: implications for obesity, insulin resistance, steatotic liver and pancreatic diseases

Faecal microbiota transplantation and glucolipid metabolic disorders: the interventional role of gut microbiota

Current status of research on the risk factors and pathogenesis of metabolic dysfunction-associated steatotic liver disease